Orexa reports promising results in post-operative recovery trial

Dutch biotech’s ORE-001 shows strong potential to prevent ileus after major surgery

Orexa B.V., a life sciences company based in the Netherlands, has announced positive interim results from its ongoing phase 2 trial investigating ORE-001 for the prevention of post-operative ileus (POI) in patients undergoing major abdominal surgery.

The multi-centre, double-blind, placebo-controlled study is being conducted in Germany and led by Prof. Alexander Mustea from Universitätsklinikum Bonn. It is enrolling up to 120 female patients undergoing gynecologic surgery requiring longitudinal…